The dental membrane and bone graft substitute market is estimated to be valued at US$ 1143.56 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membrane and bone graft substitutes are used in dental surgeries to regenerate missing or damaged tissues and bones in the oral cavity. These include collagen membranes, allografts, xenografts, synthetic membranes and bone graft substitutes. Collagen membranes are the most widely used type and help offer barrier protection and support angiogenesis during guided bone regeneration procedures. Allografts and xenografts provide bone grafting matrix derived from human and animal sources respectively, to aid bone formation. These products find applications in peri-implantitis, socket preservation, ridge augmentation, sinus lifts and periodontal defect regeneration.
Market Dynamics:
The growth of the dental membrane and bone graft substitute market is majorly driven by the increasing number of dental surgeries worldwide owing to rising incidence of dental diseases. According to the World Health Organization, oral diseases affect nearly 3.5 billion people worldwide with untreated caries in permanent teeth being the most prevalent condition assessed. Additionally, rising geriatric population prone to oral diseases and rising dental tourism in developing nations are also boosting market growth. Furthermore, technological advancements introducing bioactive bone graft materials and improved dental membrane designs are further fueling the adoption of these products. However, stringent regulatory approval process and high costs associated with advanced products may restrain market growth to a certain extent.
SWOT Analysis
Strength:
- Wide range of products for various indications and bones defects/ non-union.
- Advance technologies like tissue engineering.
- Growing demand increasing revenues of companies.
Weakness:
- Risk of infection associated with bone grafting procedures.
- Stringent regulatory framework increases compliance cost.
Opportunity:
- Emerging economies offer huge untapped market potential.
- Increasing cases of oral diseases, accidental injuries and rising awareness.
Threats:
- High cost of bone grafting surgeries limiting access in developing nations.
- Threat from other alternative bone grafting techniques.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing prevalence of dental diseases, accidental injuries and growing awareness of oral healthcare.
Regional analysis The North America dominates the global market and holds the largest market share owing to presence of advanced healthcare infrastructure, favorable reimbursement policies, and technological advancements. Asia Pacific region is expected to grow at fastest rate due to rising disposable incomes, increasing medical tourism and growing dental clinicians.
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp. These key players are focusing on new product launches, mergers and expansions to increase their market share.
Read more
Comments
0 comment